(a) Records of the Food and Drug Administration which the Commissioner has determined are not available for public disclosure, in the form of a regulation published or cross-referenced in this part, shall nevertheless be made available for public disclosure in compliance with a final court order requiring such disclosure.
(b) Where the Food and Drug Administration record ordered disclosed under paragraph (a) of this section is a record about an individual that is not available for public disclosure under § 20.63, the Food and Drug Administration shall attempt to notify the individual who is the subject of the record of the disclosure, by sending a notice to the individual's last known address.
(c) Paragraph (b) of this section shall not apply where the name or other personal identifying information is deleted prior to disclosure.
[42 FR 15616, Mar. 22, 1977, as amended at 68 FR 25287, May 12, 2003]
Notes of Decisions
Eli Lilly & Co. v. Marshall, 850 S.W.2d 155 (Tex. 1993).
· cites it 10× “While the need for confidentiality as determined by the FDA, and as promised on form 1639 and expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public…”
— 21 C.F.R. § 20.83(a) — 2 cases
Eli Lilly & Co. v. Marshall, 850 S.W.2d 155 (Tex. 1993).
“While the need for confidentiality as determined by the FDA, and as promised on form 1639 and expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public…”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.